ARISTA Biotech Confirms Antigen Test Effectiveness Against Omicron and other COVID variants
- Written by ARISTA Biotech
SINGAPORE - Media OutReach - 15 December 2021 - ARISTA Biotech Pte Ltd ("ARISTA"), manufacturer of COVID-19 antigen & antibody diagnostics, confirms that its COVID-19 antigen rapid test, which tests for the presence of SARS-CoV-2 virus in clinical specimens, is able to detect the recently identified B.1.1.529 (Omicron) variant.
On 26th November...





